28th September 2022

PHARMANOVIA ENTERS EXCLUSIVE LICENSING COLLABORATION FOR DIAZEPAM BUCCAL FILM

For Trade and Medical Media ONLY PHARMANOVIA EXCLUSIVELY LICENCES RIGHTS FOR A NOVEL WAY OF TREATING...

More information
11th July 2022

DKSH and Pharmanovia Partner to Respond to Therapeutic Needs in Southeast Asia

DKSH will support life cycle management company Pharmanovia in its mission to bring important medication to...

More information
6th July 2022

TV Interview – SkyNews

London (UK), 20 June 2022 Ian King interviews Pharmavovia’s CEO, Dr James Burt on SkyNews

More information
4th July 2022

Pharmanovia expands its footprint in China with the acquisition of Rocaltrol® from Roche

London (UK), 4 July 2022 – Pharmanovia has acquired the commercial rights in China for Rocaltrol® (calcitriol) Roche....

More information
5th April 2022

Life cycle management company Pharmanovia launches its inaugural sustainability report

The report celebrates the firm’s diversity and sets out ambitious environmental and sustainability targets London, UK...

More information
29th March 2022

Pharmanovia announces departure of Chief Corporate Development Officer Alastair Hay

LONDON – Alastair Hay is leaving his position as Chief Corporate Development Officer at the global...

More information
28th February 2022

Pharmanovia Announces Rebrand of its Benelux Business to Pharmanovia Benelux

Pharmanovia officially welcomes Lamepro B.V into the group Basildon (UK), 28 February 2022 – Pharmanovia, The life...

More information
12th November 2021

Pharmanovia to present at the Jefferies 2021 London Healthcare Conference

Basildon (UK), 10 November 2021 – Pharmanovia, the original medicines specialist globally, today announced that its...

More information
8th September 2021

Pharmanovia launches OsteoApp, creating new ways to improve the management of osteoporosis

Basildon (UK), 8 September 2021 – Pharmanovia, the original medicines specialist globally, in conjunction with their...

More information